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Original Article
Non-invasive near-infrared fluorescence
imaging of the neutrophil response
in a mouse model of transient
cerebral ischaemia
Markus Vaas1,2, Gaby Enzmann3, Therese Perinat3,
Ulrich Siler4, Janine Reichenbach4, Kai Licha5, Anja Kipar6,
Markus Rudin1,2,7, Britta Engelhardt3 and Jan Klohs1,2
Abstract
Near-infrared fluorescence (NIRF) imaging enables non-invasive monitoring of molecular and cellular processes in live
animals. Here we demonstrate the suitability of NIRF imaging to investigate the neutrophil response in the brain after
transient middle cerebral artery occlusion (tMCAO). We established procedures for ex vivo fluorescent labelling of neu-
trophils without affecting their activation status. Adoptive transfer of labelled neutrophils in C57BL/6 mice before surgery
resulted in higher fluorescence intensities over the ischaemic hemisphere in tMCAO mice with NIRF imaging when
compared with controls, corroborated by ex vivo detection of labelled neutrophils using fluorescence microscopy. NIRF
imaging showed that neutrophils started to accumulate immediately after tMCAO, peaking at 18 h, andwere still visible until
48 h after reperfusion. Our data revealed accumulation of neutrophils also in extracranial tissue, indicating damage in the
external carotid artery territory in the tMCAO model. Antibody-mediated inhibition of a4-integrins did reduce fluores-
cence signals at 18 and 24, but not at 48 h after reperfusion, compared with control treatment animals. Antibody treatment
reduced cerebral lesion volumes by 19%. In conclusion, the non-invasive nature of NIRF imaging allows studying the
dynamics of neutrophil recruitment and its modulation by targeted interventions in the mouse brain after transient experi-
mental cerebral ischaemia.
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Introduction
Transient cerebral ischaemia is followed by an inﬂam-
matory response that has been implicated to exacerbate
ischaemic injury, but also to provide the necessary
environment for regeneration and repair.1 In this
regard, the role of neutrophils following cerebral
ischaemia remains controversial. Histological studies
have revealed recruitment of neutrophils to the ischae-
mic lesion in experimental models of cerebral ischaemia
and patients with ischaemic stroke at time points when
substantial neuronal death occurs.2–4 Treatments that
prevented vascular adhesion of neutrophils,5,6 as well as
neutropenia,7,8 were found to result in a reduction of
the ischaemic damage in preclinical studies of cerebral
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ischaemia. However, clinical trials using ligands or anti-
bodies to prevent neutrophil inﬁltration into the brain
did not show clinical beneﬁts,9,10 questioning the
pathogenic role of neutrophils.
Neutrophils have been implicated in launching and
shaping the immune response following injury.
Activated neutrophils have been shown to induce
superoxide production, degranulation,11 and release
speciﬁc proteases, e.g. neutrophil elastase and matrix
metalloproteinase.12,13 In addition, neutrophils interact
with platelets, participate in ﬁbrin cross-linkage and
trigger thrombin activation by inducing the extrinsic
tissue factor/FVIIa pathway and can thereby predis-
pose the microvasculature to thrombosis.14 It could
therefore be hypothesized that neutrophils play key
roles in cerebral ischaemia injury, mainly by exerting
eﬀects on the cerebral vasculature, but direct in vivo
proof is still missing. This lack of knowledge might
largely stem from the paucity of techniques that are
able to speciﬁcally visualize neutrophil traﬃcking and
function in vivo. Histological studies (e.g. myeloperox-
idase staining) are often not speciﬁc for neutrophils
and cannot capture the dynamic and complex (inter)
actions of cells. Attempts to block neutrophil migration
in vivo might have suﬀered from lack of speciﬁcity, i.e.
other leukocyte subsets might have been blocked as
well,15 while neutrophil depletion might have caused
confounding immunological side eﬀects.16,17
More recently, the use of two-photon microscopy
enabled the intravital tracking of neutrophils in the
leptomeninges and superﬁcial parts of the cortex of
the mouse with high resolution,18 and its application
to track neutrophil in a mouse model of transient
middle cerebral artery occlusion (tMCAO) has been
recently shown.19 The technique is capable to monitor
local neutrophils dynamics and allows to directly
observe the manipulation of cell traﬃcking. However,
two-photon microscopy of the mouse brain requires a
thinned skull region or, for assessing deeper structures,
the preparation of a cranial window, which may lead to
immediate disturbances in local blood perfusion,
blood–brain barrier permeability or mechanical injuries
to the cortical surface and bleedings.20 In addition, the
method is technically limited to retrieve information
from a small ﬁeld of view and to a depth of 500 mm,
and is thus not capable to spatially resolve the neutro-
phil response in the entire brain.
Recent advances in instrumentation and image
reconstruction have led to the emergence of near-infra-
red ﬂuorescence (NIRF) imaging as a technique that
can visualize pathological processes in intact animals
using dedicated ﬂuorescent probes and reporter tech-
nology.21 NIRF imaging uses light in the spectral
range of 700–900 nm, in which absorption of endogen-
ous absorbers like oxy- and deoxygenated haemoglobin
and water is lowest and photons can penetrate deeply
into living tissue. The technique has been shown to
detect ﬂuorochromes in the brain of mice with high
sensitivity.22,23 NIRF imaging constitutes an attractive
tool for investigating mouse models of cerebral ischae-
mia. The non-invasiveness of the technique allows to
study cellular processes in the live animal with all regu-
latory processes preserved, without impeding animal
physiology and welfare, thereby enabling repetitive
assessment of the same animal. NIRF imaging has
already been applied to visualize a variety of disease-
relevant processes.24–29
Here we present an approach using adoptive transfer
of ﬂuorescently labelled neutrophils to monitor the
dynamics of neutrophil accumulation in the mouse
brain after the tMCAO with planar NIRF imaging.
Our data revealed accumulation of neutrophils in the
ischaemic brain but also in extracranial tissue.
Moreover, we employed NIRF imaging to assess the
role of a4-integrins in mediating neutrophil accumula-
tion to the ischaemic brain in vivo.
Materials and methods
Animals and treatment
All procedures conformed to the national guidelines of
the Swiss Federal act on animal protection and were
approved by the Cantonal Veterinary Oﬃce Zurich
(Permit Number: 18-2014 and 49-2011). We conﬁrm
compliance with the ARRIVE guidelines on reporting
animal experiments.
Male C57BL/6J mice (Janvier, France), weighing
20–25 g, of 8–10 weeks of age were used, randomly
assigned to the experimental groups. Animals were
housed in a temperature controlled room in individu-
ally ventilated cages, containing up to ﬁve animals per
cage, under a 12-h dark/light cycle. Paper tissue was
given as environmental enrichment. Food
(3437PXL15, CARGILL) and water were provided ad
libitum.
Experimental protocols
VLA-4-mediated adhesion of neutrophils was blocked
by intravenous infusion of rat anti-mouse a4-integrin
(clone PS/2, 100 mg/mouse) 15min prior to surgery,
while control mice received rat anti-mouse endoglin
(clone MJ7/18, 100mg/mouse). Both antibodies were
generated endotoxin-free in house. No randomization
was applied. Using G*Power 3.1 software (Heinrich-
Heine-Universita¨t, Du¨sseldorf, Germany; http://www.
gpower.hhu.de/), a sample size of n 10 per group
was calculated a priori for the primary end point nor-
malized ﬂuorescence intensities over the ipsilateral
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brain at 18 h after reperfusion, assuming an eﬀect size
d¼ 1.7, at a¼ 0.05 and b¼ 0.2. A total of 26 mice
received intravenously either rat anti-a4-integrin anti-
body (n¼ 13) or isotype control (n¼ 13).
Focal cerebral ischaemia
Transient MCAO was induced using the intraluminal
ﬁlament technique.30 Anaesthesia was initiated by
using 3% isoﬂurane (Abbott, Cham, Switzerland).
Anaesthesia was maintained with 1.5–2% isoﬂurane in
a mixture of O2 (200ml/min) and air (800ml/min), sup-
plied via face mask. Before the surgical procedure, a
local analgesic (Lidocaine, 0.5%, 7mg/kg) was adminis-
tered subcutaneously. Temperature was controlled
during the surgery and kept constant at 37 0.5C
with a feedback-heating controlled pad system. For
tMCAO, a midline neck incision was made and the left
common carotid artery (CCA) was ligated proximal of
the bifurcation of the internal carotid artery (ICA) and
external carotid artery (ECA). Subsequently, the left
ECA was isolated and ligated and a suture was placed
around the ICA to temporarily restrict blood ﬂow. A
small incision was made in the CCA and an 11-mm
long silicone-coated monoﬁlament (171956PK5Re,
Doccol Corporation, USA) was introduced and
advanced until it occluded the middle cerebral artery
(MCA). A suture around the ICA secured the ﬁlament
in position. After occlusion of the vessel, animals were
transferred to a heated recovery box and allowed to
wake up. After 60min, animals were reanaesthetized.
The ﬁlament was withdrawn and the ICA was ligated.
Sham-operation involved surgical procedures, without
occlusion of the middle cerebral artery. After surgery
buprenorphine was administered as s.c. injection
(Temgesic, 0.1mg/kg b.w.) and animals were placed in
a heated recovery box for 2 h. Buprenorphine was then
given twice s.c. every 6–8h on the day of surgery and
thereafter supplied via drinking water (1mg/kg) for 36h.
Animals receive softened chow in a Petri-dish placed on
the ﬂoor of their cages to encourage eating. Animals
were excluded from the studies when they fulﬁlled one
of the following criteria: prolonged surgery time
(>15min); no reﬂow after ﬁlament withdrawal; dead
before experimental endpoint. Mortality rate was 0%.
Characterization of the neutrophil
response in the blood
Whole blood (50 ml) was collected by saphena vein
punctuation into EDTA-coated tubes (Sarstedt,
Nu¨mbrecht, Germany) 3 times prior to tMCAO (base-
line), at 0.5, 1.5, 4, 24 or 48 h after reperfusion or cor-
responding sham surgery in a random fashion (n 9
per time point). Samples were incubated at room
temperature (RT) for 15min with both an anti-Ly6G-
PE (clone 1A8) and an anti-Ly6G/Ly6C-APC antibody
(clone Gr1, both BD Pharmingen, Germany), followed
by a red blood cell lysis containing 1.5% PFA (500 ml,
10min, RT, BD Pharmingen, Switzerland) and kept on
ice until they were analysed with a GalliosTM Flow
Cytometer (Beckman Coulter, Switzerland). Up to
10,000 events were acquired and examined for the
expression of Ly6C and Ly6G using the Kaluza
Analysis Software (Beckman Coulter, USA).
Isolation of neutrophils from bone marrow
Mice were sacriﬁced by cervical dislocation after given
deep 3% isoﬂurane anaesthesia. Femur and tibia from
both legs were removed, and the extreme distal tip of
each bone was cut oﬀ under sterile conditions and bone
marrow was ﬂashed out with HBSS. After dispersing
cell aggregations, red blood cells were lysed with 20ml
of a 0.83% ammonium chloride and Tris-HCl 9:1 (pH
7.5) buﬀer. Lysis was stopped by adding 30ml HBSS.
The suspension was centrifuged (400 g, 6min, 4C) and
cell pellet was resuspended in 10ml HBSS. Neutrophils
were separated through two Percoll gradient (GE
Healthcare, Uppsala, Sweden) centrifugations steps
(64.8% and 61.5% Percoll, 1000 g, 20 and 35min, 4C).
We obtained 5 1.5 106 neutrophils per mouse.
Fluorescent labelling of neutrophils and viability assay
To identify a suitable NIRF dye for neutrophil label-
ling neutrophils were incubated in HBSS (0.2 106
cells/10 ml) for 15min at RT together with either 5,
10, 25 or 50 mg/ml of VivoTrack680 (Perkin Elmer,
USA) or LIPO-6S-IDCC (Freie Universita¨t Berlin,
Germany). To establish the optimal LIPO-6S-IDCC
concentration, neutrophils were incubated with either
5, 10, 25, 50, 100, 250 or 500 mg/ml of dye for 15min.
To determine the optimal incubation time, neutrophils
were incubated with 25 mg/ml of LIPO-6S-IDCC for 5,
10, 15, 20, 25 or 30min. Fluorescence was measured
using a GalliosTM Flow Cytometer. To assess cell via-
bility, 10 ml of an aqueous solution of propidium iodide
(0.1mg/ml) was added 10 s before ﬂow cytometric ana-
lysis. Electronic gating was used to diﬀerentiate viable
cells from apoptotic cells.
Neutrophil activation assays
LIPO-6 S-IDCC labelled or unlabelled neutrophils iso-
lated from two animals were resuspended in Dulbecco’s
phosphate-buﬀered saline supplemented with 2.5% calf
serum and 0.1% NaN3. Aliquots of 0.3 106 neutro-
phils per 200 ml were distributed in a 96-well round
bottom microtiter plate and centrifuged at 330 g at
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4C for 3min. The pellets were dislodged and
incubated with the following directly conjugated
rat antibodies at 10 mg/ml for 30min on ice: CD45
APC (BioLegend 103112, clone 30F11); Ly6G APC/
Cy7 (BioLegend127624, clone 1A8); LFA-1 FITC
(CD11a, BD 01204D, clone 2D7); Mac-1 PB
(CD11b, BioLegend 101224, clone M1/70); CD49d
PE (integrin-a4, Southern Biotech 1520-09, clone PS/
2); PSGL-1 AF647 (clone 4RA10, conjugated in
house); L-selectin FITC (CD62L, BD 553150, clone
Mel-14). In parallel, selected aliquots were incubated
with appropriate isotype controls. Last, all cells were
washed several times and ﬁxed with 1% PFA/PBS for
ﬂow cytometry.
NIRF imaging
NIRF imaging was performed with the Maestro 500
multispectral imaging system (Cambridge Research &
Instruments Inc, USA). A band pass ﬁlter (615–665 nm)
was used for excitation. The ﬂuorescence was detected
by a CCD camera ﬁtted with a long pass ﬁlter (700 nm).
Fluorescence emission images were acquired by incre-
mentally increasing the excitation wavelengths over the
indicated range. NIRF images were subjected to spec-
tral unmixing using the CRi Maestro Image software.
Determination of detection sensitivity
in a silicone phantom
A tissue like silicone phantom was produced as previ-
ously described.31 The absorption coeﬃcient (ma) of
0.2 cm1 and a scattering coeﬃcient (m’s) of 10 cm
1
were adapted to match the optical properties of the
brain. Exchangeable micropipettes (volume 1 ml per
15mm, Brand GmbH & Co. KG, Germany) were
placed in a hole at 2mm depth parallel to the surface
of the phantom (Figure 3(b)). Micropipettes containing
either 750, 1000, 1750, 2500, 5000 or 10,000 neutro-
phils/ml were placed within the phantom for NIRF ima-
ging. Image analysis consisted of drawing a region of
interest (ROI) over the area containing the neutrophil
suspension, measuring the average ﬂuorescence inten-
sity of all pixels within the ROI divided by the factor of
their area.
NIRF imaging in vivo
LIPO-6S-IDCC-labelled neutrophils (7.5 106 0.5
106 cells) were adoptively transferred by intravenous
injection 15min prior to tMCAO or sham surgery. To
establish the time course of neutrophil accumulation,
31 mice were serially imaged in a staggered design up to
6 times within 48 h (sham n¼ 9–15 and tMCAO n¼ 7–
10). For the anti-a4-integrin treatment study mice were
serially imaged at 18 h (isotype control n¼ 11; rat anti-
a4-integrin n¼ 10), 24 h (isotype control n¼ 12; rat
anti-a4-integrin n¼ 11) and 48 h after tMCAO (isotype
control n¼ 12; rat anti-a4-integrin n¼ 12). In few ani-
mals, we missed the time point for imaging. Mice were
anaesthetized with 1.5–2% isoﬂurane in an oxygen/air
mixture (1:4) and the skin overlying the head was depi-
lated. Animals were placed onto an animal support into
which a warm-water circuit was integrated to maintain
body temperature. ROIs were manually drawn over
the right and left hemisphere and temporal muscles
(Figure 4(a)). The person was blinded to the experimen-
tal group. Animals with skin irritations or wounds
were excluded from analysis. The average ﬂuorescence
intensity of all pixels within the ROI were measured
and divided by the factor of their area. Normalized
ﬂuorescence intensities were calculated by dividing the
mean ﬂuorescence intensity of the ipsilateral side by the
mean ﬂuorescence intensities of the contralateral
sideX 100.
Tissue processing
Animals were put under deep anaesthesia by intraper-
itoneal injection of ketamine/xylazine/acepromazine
maleate (100/20/3mg/kg body weight) and transcar-
dially perfused with 20ml PBS, followed by 1% par-
aformaldehyde in PBS (pH 7.4; PFA). For images
shown in Figure 1 and 5 paraﬃn embedding of
tissue was performed. Whole heads were removed
and ﬁxed in 4% PFA for approximately 48 h (mice
sacriﬁced after 24 h of reperfusion after tMCAO)
after removal of the skin. Cuts between the eyes and
removing of the occipital plates were performed to
ensure PFA access to the brain. Skulls were decalciﬁed
in Citrate EDTA Buﬀer pH 7.5 (Quartett, Germany)
for 7 days, then sliced (coronary sections, 2-mm slices,
caudal direction from nose) and routinely paraﬃn wax
embedded.
For images shown in Figure 4, brains were immedi-
ately removed and sliced (coronary sections at Bregma
1 0.3mm and 5.1 0.1mm), snap frozen in
Tissue-TEK O.C.T. (Sysmex Suissie AG,
Switzerland) in a 2-methylbutane (Sigma-Aldrich,
Switzerland) dry ice bath and stored at 80C.
Histology and immunohistochemistry
Consecutive 5-mm-thick sections were prepared from
frozen brain blocks and paraﬃn blocks from the
heads (coronary sections) and were either stained with
haematoxylin and eosin (HE, Sigma-Aldrich) or sub-
jected to immunohistochemistry for the demonstration
of neutrophils as described before.32 Cryosections were
ﬁxed with acetone for 10min at 20C and rehydrated
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Figure 1. Systemic neutrophil mobilization and attraction to the site of ischaemic damage following tMCAO. (a) Flow cytometry
showed a significant increase in the amount of circulating neutrophils at 1.5 and 4 h of reperfusion after 1 h of tMCAO (grey) or sham
surgery (white), but dropped to pre-surgery levels thereafter. Neutrophil levels in sham and tMCAO animals did not differ significantly.
These results are indicative of neutrophil mobilization as an immediate response to surgery. Centre lines show the medians; box limits
indicate the 25th and 75th percentiles; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles.
Repeated-measures ANOVA and Holm–Sidak, baseline n¼ 13, sham n¼ 9, MCAO n¼ 9–11 per group for all time points, *p< 0.05 vs
baseline. (b) Sketch to highlight the location and extent of the ischaemic lesion in a coronal brain section (Bregma 0.74mm), and
indicating where images (c–h) were acquired. (c–h) Representative images of a mouse brain after 1 h of tMCAO and 24 h after
reperfusion to show the presence and distribution of neutrophils (Ly6Gþ) in paraffin sections. (c,e,g) Contralateral hemisphere
showing no neutrophil influx in the leptomeninges (c), cortex (c,e) and striatum (g). (d,f,h) Inspection of the ipsilateral hemisphere
revealed that Neutrophils are present in low numbers within leptomeningeal vessels (d, long arrow) and individually within paren-
chymal vessels (short arrows) in cortex (d,f) and striatum (h). A few individual neutrophils are also seen outside blood vessels, in the
parenchyma (arrowheads). Avidin biotin complex method, haematoxylin counterstain. Bars¼ 10mm.
Vaas et al. 5
in PBS for 5min. Sections prepared from paraﬃn
embedded heads were deparaﬃnized and incubated
with citrate buﬀer (pH 6.0, 20min at 98C) for antigen
retrieval. Incubation with the primary rat anti-Ly6G
antibody (clone 1A8, Biolegend) was performed for
deparaﬃnized sections at 4C for 15–18 h and for cry-
sections at RT for 1 h, respectively. All sections were
subsequently incubated with a biotinylated secondary
Figure 2. Labelling of neutrophils for NIRF imaging. (a) Comparison of the fluorescence intensities measured by flow cytometry
after incubation of neutrophils with different concentrations of LIPO-6S-IDCC and VivoTrack 680. Centre lines show the medians;
box limits indicate the 25th and 75th percentiles; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles.
n¼ 9; *p< 0.05 by repeated-measures ANOVA and Tukey’s test. (b) Confocal microscopy images of neutrophils after incubation with
LIPO-6S-IDCC and anti-Ly6G-PE antibody. Depicted are cells in the (i) transmitted light, (ii) LIPO-6S-IDCC red channel, (iii) Ly6G
green channel and (iv) the overlay. Bar¼ 10mm. (c) Incubation of neutrophils with different concentrations of LIPO-6S-IDCC. The
propidium iodide assay was used to assess the effect of labelling on cell viability. Mean SD; n¼ 3 animals with three independent
experiments each, *p< 0.05 by one-way ANOVA with Tukey’s posttest. (d) Incubation of neutrophils with 25mg/ml LIPO-6S-IDCC for
different time intervals. Mean SD, n¼ 3 animals with three independent experiments each; *p< 0.05 by one-way ANOVA with
Tukey’s posttest. CTRL¼ control.
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anti-rat antibody (RT, 30min) and thereafter with a
preformed streptavidin–biotin complex (RT, 30min;
both Vectastain ABC-Kit, Vector Laboratories,
USA). Visualization with diaminobenzidin or
Figure 4. Tracking of neutrophils to the ischaemic lesion in
C57BL/6 mice in vivo. (a) In vivo NIRF images of the mouse head.
Depicted are a sham-operated mouse 25 h after adoptive transfer
of LIPO-6S-IDCC-labelled neutrophils (left) and a mouse sub-
jected to 1 h tMCAO and 24 h of reperfusion in which LIPO-6S-
IDCC-labelled neutrophils were adoptively transferred prior to
ischaemia (right). Examples of regions of interests drawn over the
brain hemispheres and muscle regions are shown (dashed line).
(b) Normalized fluorescence intensities over the ipsilateral
ischaemic and contralateral brain regions. Mean SD; sham
n¼ 15, tMCAO n¼ 10; Kruskal–Wallis one-way ANOVA fol-
lowed Dunn’s pairwise multiple comparison; *p< 0.05 vs
contralateral, #p< 0.05 vs sham. (c) The time course of neu-
trophil accumulation in the brain was assessed with non-invasive
NIRF imaging. Mean SD, sham n¼ 9–15, tMCAO n¼ 7–10 per
group for all time points; repeated-measures ANOVA and
Holm–Sidak pairwise multiple comparison; *p< 0.05 vs 2 h,
#p< 0.05 vs sham (d) Fluorescence microscopy of cryosections
of a tMCAO mouse brain 18 h after injection of labelled neu-
trophils. Avidin biotin complex method, haematoxylin counter-
stain. Shown are LIPO-6S-IDCC-labelled neutrophils (arrows)
and endogenous (Ly6Gþ) neutrophils (arrow head).
Bars¼ 50mm.
Figure 3. Fluorescence intensity as a function of the number of
labelled neutrophils. (a) Set-up for NIRF imaging. Excitation light
from a white light source is filtered and directed to the mouse
head. Fluorescence is detected using a charged-couple device
(CCD) camera fitted with adequate emission filters. (b)
Illustration of a silicon phantom mimicking brain tissue. A glass
capillary was inserted at a depth of 2mm and filled with sus-
pensions containing different numbers of LIPO-6S-IDCC-labelled
neutrophils. (c) Fluorescence intensities as a function of the
number of LIPO-6S-IDCC-labelled neutrophils. Fluorescence
intensities were measured in a region of interest of
15mm 6mm over the centre of the phantom. Mean SD of
three independent experiments.
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peroxidase substrate (AEC Kit, Vector Laboratories)
was followed by haematoxylin (Sigma-Aldrich) coun-
terstaining. All sections were mounted with an aqueous
medium (Aquatex, Millipore). To assess the eﬀects of
a4-integrin blockade on neutrophil numbers, brain sec-
tions were inspected by a person blinded to the treat-
ment group.
Detection of LIPO-6S-IDCC labelled neutrophils in
brain sections
To diﬀerentiate adoptively transferred LIPO-6S-IDCC
positive from endogenous neutrophils, cryosections
(7 mm) were subjected to a Ly6G immunohistochemis-
try (described above) and imaged with a LSM710
(Zeiss, Germany) for ﬂuorescence and a Panoramic
Digital Slide Scanner (3DHISTEC, Hungary) to
obtain brightﬁeld images. Images were co-registered
after imaging.
Neutrophil count
Absolute numbers of Ly6Gþ neutrophils were deter-
mined at ﬁve levels spanning the entire lesion, i.e. at
Bregma þ2.8, þ1.54, þ0.14, 1.94 and 4.6mm, in
both hemispheres. We diﬀerentiated between neutro-
phils located to the meninges and parenchymal cells.
The latter term was used for simpliﬁcation only and
does not imply extravasation of neutrophils into the
brain parenchyma.
Determination of cerebral lesion volumes
Five 7 mm thick coronal HE-stained cryosections (taken
at Bregma þ2.8, þ1.54, þ0.14, 1.94 and 4.6mm)
were digitized with a Panoramic Digital Slide Scanner
(3DHISTEC, Hungary) at 20 magniﬁcation. Lesions
were determined with NDP.view.4.26 (Hamamatsu
Photonics K.K.). The person was blinded with respect
to the treatment groups. Cerebral lesion volumes were
calculated by summing up the volumes of each section
and correcting for oedema (isotype control group
n¼ 10; anti-a4-integrin treated n¼ 13).
Statistical analysis
Data are presented as mean SD. Comparisons were
made by one-way ANOVA or repeated measures
ANOVA followed by Holm–Sidak or Tukey’s test,
ANOVA on ranks followed by Dunn’s test, or
Mann–Whitney rank sum test where applicable. A
Spearman’s correlation analysis was performed
between the number of neutrophils in the phantom
and measured ﬂuorescence intensities. A p-value< 0.05
was considered signiﬁcant.
Figure 5. Neutrophil accumulation in the temporal muscle
after external carotid artery ligation. (a) Fluorescence intensities
measured over the left (ipsilateral) and right (contralateral)
temporal muscles of sham-operated mice and animals subjected
to 1 h of tMCAO and 24 h of reperfusion. LIPO-6S-IDCC-
labelled neutrophils were intravenously injected 15min prior
surgery and NIRF imaging was performed 24 h after the inter-
vention. Mean SD, sham n¼ 15 and tMCAO n¼ 10; Kruskal–
Wallis one-way ANOVA followed Dunn’s pairwise multiple
comparison; *p< 0.05 vs contralateral. (b–e) Ly6G immunohis-
tochemistry with avidin biotin complex method and haema-
toxylin counterstain of paraffin sections of the temporal muscle.
(b) Ipsilateral and (c) contralateral temporal muscle of a sham-
operated mouse. (d) Ipsilateral and (e) contralateral temporal
muscle of a mouse subjected to tMCAO. (b,d) Individual neu-
trophils were observed within interstitial vessels (arrows in high
magnification insets) in the ipsilateral muscles of both sham-
operated and tMCAO mice. In the muscle of the tMCAO mouse,
individual degenerate myofibres are observed (arrow heads in
high magnification inset). (c,e) The contralateral temporal mus-
cles were unaltered. Bar¼ 20mm (overviews) and 10mm (high
magnification insets).
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Results
Systemic neutrophil mobilization and neutrophil
attraction to the ischaemic territory after tMCAO
To evaluate eﬀects of the placement of the intraluminal
ﬁlament on the number of circulating neutrophils, we
serially quantiﬁed blood neutrophils after 1 h of
tMCAO in male C57BL/6 mice using ﬂow cytometry
(the gating strategy is shown in Supplementary
Figure 1). Serial blood samples were taken from
C57BL/6 mice, prior to and 0.5, 1.5, 4, 24 and 48 h
after 1 h of tMCAO or sham-surgery (Figure 1(a)).
Neutrophil counts were signiﬁcantly higher in the
blood of sham mice at 1.5, 4 and 24 h, while in
tMCAO mice signiﬁcant higher neutrophil counts
were detected at 0.5, 1.5, 4 and 24 h after reperfusion
(p< 0.05 vs baseline). There were no statistical signiﬁ-
cant diﬀerences between sham and tMCAO animals at
0.5, 1.5, 4 and 24 h after reperfusion (p> 0.05 pairwise
comparison). This indicates that the systemic neutro-
phil response was dominated by the surgical interven-
tion required in this model.
We next analysed the ischaemic brain lesion in
tMCAO mice for the presence of neutrophils at 24 h
after reperfusion (Figure 1(c–h)), as it has previously
been shown that neutrophils are most abundant in
the brain between 18 and 24 h after tMCAO.32 As
expected,33 the lesion induced by 1 h of tMCAO and
24 h of subsequent reperfusion was represented by
extensive necrosis and oedema in the striatum and neo-
cortex that extended beyond the middle cerebral artery
territory within the ipsilateral hippocampus and thal-
amus. Neutrophils (Ly6Gþ) were found in association
with the lesions in low numbers. They were predomin-
antly seen individually within small vessels in the adja-
cent leptomeninges and the aﬀected parenchyma,
occasionally also outside vessels in the aﬀected paren-
chyma (Figure 1(d,f,h)), conﬁrming previous
reports.32,34 The contralateral hemisphere was generally
free from neutrophils (Figure 1(c,e,g)). In brains of
sham-operated mice, only few Ly6Gþ cells were
detected in leptomeningeal vessels (data not shown).
This conﬁrms that neutrophils are recruited into the
brain as a consequence of the ischaemic tissue injury.
Plasma membrane labelling of neutrophils for NIRF
imaging does not lead to cell activation
NIRF imaging requires labelling of neutrophils, a pro-
cedure which should ideally neither alter the pheno-
type nor the function of neutrophils. We aimed at
establishing a protocol for ex vivo labelling of neutro-
phils isolated from the bone marrow of C57BL/6
mice. Puriﬁed neutrophils were incubated with the
NIRF dyes VivoTrack680 or LIPO-6S-IDCC at diﬀer-
ent dye concentrations. Cells showed higher ﬂuores-
cence intensities when labelled with LIPO-6S-IDCC
compared with VivoTrack680 at all concentrations
tested (Figure 2(a), LIPO-6S-IDCC 173 52,
198 54, 332 21, 414 37 vs VivoTrack680 12 2,
29 1, 60 6, 94 12, p< 0.05). Confocal microscopy
revealed that LIPO-6S-IDCC labels the plasma mem-
branes of Ly6Gþ cells (Figure 2(b)). To determine the
optimal dye concentration for neutrophil labelling, we
incubated equal numbers of harvested neutrophils
with diﬀerent amounts of LIPO-6S-IDCC dye for
15min and analysed the samples by ﬂow cytometry
(Figure 2(c)). In addition, neutrophils were incubated
with propidium iodide to assess adverse eﬀects on cell
viability. Fluorescence emission increased with increas-
ing concentrations of LIPO-6S-IDCC with a max-
imum at 25 mg/ml LIPO-6S-IDCC. Thereafter,
ﬂuorescence intensities decreased, likely due to self-
quenching. The proportion of non-viable neutrophils
was higher in LIPO-6S-IDCC than in unlabelled cells
at all concentrations tested (Figure 2(c)), and concen-
trations above 50 mg/ml led to a further increase in the
number of non-viable cells. Furthermore, to ﬁnd the
optimal incubation time, we incubated neutrophils
with 25 mg/ml of LIPO-6S-IDCC for diﬀerent periods
of time (Figure 2(d)). Flow cytometry revealed
increasing ﬂuorescence emission with increasing incu-
bation times, but with incubation times longer than
20min, the proportion of non-viable cells increased
signiﬁcantly. Thus, a concentration of 25 mg/ml
LIPO-6S-IDCC and an incubation time of 20min con-
stituted a good compromise between cell viability and
ﬂuorescence intensity.
To determine whether in vitro labelling of neutro-
phils with LIPO-6S-IDCC results in their activation,
neutrophils were isolated from the bone marrow of
two C57BL/6 mice and pooled. Half of the cells were
incubated with 25 mg/ml LIPO-6S-IDCC for 20min,
while the unlabelled fraction served as control. Cells
were stained with directly conjugated rat antibodies
recognizing CD45, Ly6G, CD62L (L-selectin), CD11a
(LFA-1) and CD11b (Mac-1). Cell surface expression
of the activation markers CD62L, CD11a and CD11b
on Ly6Gþ/CD45þ neutrophils was assessed by ﬂow
cytometry (Supplementary Figure 2A). LIPO-6S-
IDCC labelling induced only negligible shedding
(reduction of 8%) of membrane associated L-
selectin (CD62L) compared with unlabelled cells
(Supplementary Figure 2B). In addition, we did not
detect an increased expression of CD11a and CD11b
on neutrophils in response to the labelling procedure
with LIPO-6S-IDCC (Supplementary Figure 2C, D),
underscoring that this labelling procedure does not acti-
vate the neutrophils.
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NIRF imaging enables monitoring of neutrophil
accumulation to the ischaemic lesion in vivo
For the non-invasive whole brain visualization of neu-
trophil traﬃcking, we have used a planar NIRF ima-
ging system operated in reﬂectance mode (Figure 3(a)).
Light from a white light source was directed through a
band pass ﬁlter to the head of the anaesthetized animal.
The emitted ﬂuorescence was captured using a CCD
camera ﬁtted with adequate emission ﬁlters and a lens
to adjust the focal plane. To evaluate the capacity of
NIRF imaging to detect ﬂuorescently labelled neutro-
phils, we ﬁrst used brain tissue mimicking silicon phan-
toms (Figure 3(b)). To simulate optical tissue properties
of the mouse brain, TiO2 particles and carbon black
powder were added as scattering and absorbing agent,
respectively. Diﬀerent numbers of LIPO-6S-IDCC-
labelled neutrophils in suspension were ﬁlled into a
glass capillary, which was inserted at a 2mm depth
below the surface of the phantom. We found a linear
correlation between the measured ﬂuorescence intensi-
ties and the number of neutrophils in the centre of the
glass capillary (Figure 3(c), R2¼ 0.98, p< 0.05). A min-
imum number of 1750 LIPO-6S-IDCC-labelled neutro-
phils in a volume of 1.5ml could be distinguished from
the background of the phantom.
For NIRF imaging of neutrophil accumulation in
the ischaemic brain in vivo, we intravenously injected
7.5 0.5 106 LIPO-6S-IDCC-labelled neutrophils
into mice 15min prior to tMCAO. NIRF imaging
was performed 24 h after reperfusion (Figure 4(a,b)).
Sham-operated animals injected with LIPO-6S-IDCC-
labelled neutrophils served as controls. In tMCAO
mice and sham-operated animals, injection of ﬂuores-
cently labelled neutrophils resulted in signiﬁcant higher
ﬂuorescence intensities over the left ischaemic hemi-
sphere compared with the contralateral hemisphere
(ipsilateral tMCAO 168 42%, ipsilateral sham
111 4% vs contralateral, p< 0.05). Yet, the ﬂuores-
cence intensities were signiﬁcantly higher in tMCAO
animals as compared with shams (p< 0.05). To estab-
lish the time course of neutrophil traﬃcking to the
brain in vivo, we adoptively transferred LIPO-6S-
IDCC-labelled neutrophils before tMCAO and rec-
orded ﬂuorescence intensities longitudinally with
NIRF imaging (Figure 4(c)). We observed a steady
increase in ﬂuorescence over the ischaemic hemisphere
in tMCAO mice injected with LIPO-6S-IDCC-labelled
neutrophils. Normalized ﬂuorescence intensities were
signiﬁcantly higher in the interval at 18 to 48 h com-
pared with 2 h after reperfusion (p< 0.05). In sham-
operated mice, there was only a minor increase in nor-
malized ﬂuorescence intensities observed over the ipsi-
lateral hemisphere. Normalized ﬂuorescence intensities
in the ipsilateral hemisphere was signiﬁcantly higher in
tMCAO at all time points (p< 0.05). A subgroup of
tMCAO animals that were injected with LIPO-6S-
IDCC-labelled neutrophils were sacriﬁced at 18 h
after reperfusion. Fluorescence microscopy and immu-
nohistochemistry demonstrated that both exogenously
labelled neutrophils and endogenous neutrophils
(Ly6Gþ) were present in the ischaemic territory
(Figure 4(d)). The LIPO-6S-IDCC-labelled neutrophils
made up approximately 50% of all neutrophils and
appeared morphologically unaltered. Taken together,
these ﬁnding indicates that labelled neutrophils are
recruited to the site of ischaemic injury.
Interestingly, we detected signiﬁcantly higher nor-
malized ﬂuorescence intensities over the ipsilateral tem-
poral muscle compared with the contralateral side in
tMCAO mice and sham-operated mice at 24 h of reper-
fusion (Figure 5(a), ipsilateral tMCAO 249 76%, ipsi-
lateral sham 135 16% vs contralateral, p< 0.05).
There was no signiﬁcant diﬀerence in normalized ﬂuor-
escence intensities of the ipsilateral muscle between
sham and tMCAO animals (p> 0.05). This prompted
us to further investigate the source of the ﬂuorescence
signal. Ly6G immunohistochemistry identiﬁed presence
of numerous neutrophils in the ipsilateral muscle
mainly in interstitial vessels in sham and tMCAO ani-
mals, which was not observed in the corresponding
contralateral temporal muscles (Figure 5(b–e)). These
ﬁndings indicate that the ﬂuorescence signal originated
not from the ischaemic lesion but is due to neutrophil
traﬃcking into the temporal muscle.
4-integrins mediate post-ischaemic neutrophil
accumulation in the CNS in vivo
Intravascular guiding cues direct neutrophils to sites of
tissue damage.4 In light of a recent study proposing
binding of neutrophils via VLA-4,19 we investigated
the eﬀect of a blockade of a4-integrins on neutrophil
traﬃcking with NIRF imaging. The a4-integrin subunit
can pair with the b1-integrin subunit to form VLA-4,
which binds to VCAM-1,35 ﬁbronectin and JAM-B on
brain endothelial cells in the mouse. Blockade of a4-
integrin by the monoclonal antibody PS/2 signiﬁcantly
reduced the interaction of neutrophils with cerebral
blood vessels at the site of ischaemic cerebral injury
and consecutively reduced the damage in the tMCAO
model.19 We serially performed NIRF imaging at 18, 24
and 48 h of reperfusion following antibody-mediated
inhibition of a4-integrins. In each group, one mouse
had to be excluded from analysis due to skin irritation
caused by epilation procedure. Anti-a4-integrin anti-
body treated animals had signiﬁcantly reduced ﬂuores-
cence intensities over the left ischaemic hemisphere at
18 and 24 h after tMCAO compared with animals that
received a control antibody (Figure 6(a), anti-a4-
10 Journal of Cerebral Blood Flow & Metabolism
integrin 117 27% and 135 31% vs control antibody
155 19% and 165 23%, p< 0.05), indicating sub-
stantially reduced neutrophil accumulation in the
ischaemic hemisphere. At 48 h, ﬂuorescence intensities
were not signiﬁcantly diﬀerent between anti-a4-integrin
antibody treated animals and controls (anti-a4-integrin
antibody 185 51% vs control antibody 186 25%,
p> 0.05). For cross-validation, we counted neutrophils
in brain sections of a subgroup of animals euthanized at
the endpoint at 48 h after reperfusion (Figure 6(b)). We
found no signiﬁcant diﬀerences in the total number of
neutrophils between the two groups (anti-a4-integrin
antibody 603 313 vs control antibody 384 123,
p> 0.05). Moreover, we assessed the eﬀect of anti-a4-
integrin antibody on the ischaemic damage on HE
stained tissue cryosections (Figure 6(c)). Three brains of
the control group were excluded due to damage during
tissue processing. Cerebral lesion volumes were reduced
by 19% in anti-a4-integrin antibody treated as compared
with control antibody treated animals 48 h after reperfu-
sion (anti-a4-integrin antibody 57.8 14.0mm3 vs
71.2 15.3mm3, p< 0.05) concomitant with an early
reduction of neutrophil accumulation.
Discussion
In the current study, we used NIRF imaging to non-
invasively track ﬂuorescently labelled and adoptively
transferred neutrophils to the ischaemic brain in mice.
We have isolated neutrophils from the bone marrow of
C57BL/6 mice, which have been previously shown to be
morphologically mature and functionally competent.36
We ﬁrst established an optimized protocol for labelling
neutrophils ex vivo with the NIRF dye LIPO-6S-IDCC
minimizing negative eﬀects of the labelling on cell via-
bility with increasing dye concentrations and incuba-
tion times. In addition, we examined whether the
labelling procedure leads to neutrophil activation,
which would be undesirable for traﬃcking studies.
Most leukocytes constitutively express L-selectin med-
iating tethering and rolling along the endothelium.
Upon activation of the leukocytes, the extracellular
domain of L-selectin is generally shed from the sur-
face.37 In parallel, it is widely acknowledged that the
surface expression of Mac-1 (CD11b/CD18, aMb2) is
increased due to mobilization of intracellular reser-
voirs.38 Surface levels of LFA-1 (CD11a/CD18, aLb2)
do not seem to be aﬀected in that process.39 We
observed only minute shedding of L-selectin in the
LIPO-6S-IDCC labelled neutrophil population and
surface expression of aMb2 and aLb2 integrins was
indistinguishable between labelled and unlabelled neu-
trophils. This underscores that the labelling does not
trigger activation of labelled neutrophils to a signiﬁcant
level.
Non-invasive monitoring of neutrophil recruitment
puts high demand on the detection sensitivity of the
imaging methods because neutrophil accumulation in
the mouse brain after tMCAO was reported to be rela-
tively low.40,32,34 We have found that NIRF imaging
can detect as few as 1750 LIPO-6S-IDCC-labelled neu-
trophils in a homogenous phantom mimicking brain
tissue. However, when non-invasively imaging the
mouse head contributions from all compartments of
the head including skin, bone, muscles, meninges, and
brain have to be considered. Hence, generation of a
detectable contrast does not only depend on the
number of accumulated cells in the ischaemic territory
Figure 6. a4-integrins mediate neutrophil accumulation to the ischaemic lesion in vivo. (a) Normalized fluorescence intensities
measured over the ischaemic hemisphere of mice. Mean SD, anti-a4-integrin n¼ 10–12, control n¼ 11–12, Mann–Whitney rank
sum test, *p< 0.05. (b) Absolute numbers of Ly6Gþ neutrophils were determined in anti-Ly6G stained brain cryosections at five levels
spanning the entire lesion, i.e. at Bregma þ2.8, þ1.54, þ0.14, 1.94 and 4.6mm, in both hemispheres. Mean SD, anti-a4-integrin,
n¼ 4, control n¼ 5, Mann–Whitney rank sum test, *p< 0.05. (c) Oedema corrected cerebral lesion volumes at 48 h after reperfusion.
Mean SD, anti-a4-integrin n¼ 13, control antibody, n¼ 10, Mann–Whitney rank sum, *p¼ 0.05 vs control antibody.
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but also on the optical properties of the various tissue
compartments and the biodistribution of the labelled
cells after adoptive transfer.
The injection of LIPO-6S-IDCC-labelled cells in
sham-operated animals led to an increase in ﬂuores-
cence of both hemispheres with a minor contrast
between the ipsi- and contralateral side. The ﬂuores-
cence of the contralateral hemisphere is likely due to
labelled neutrophil circulating in the blood (5–10% of
the total neutrophils) and in the bone marrow of the
skull, which is a main site of neutrophil clearance.41
The slightly higher ﬂuorescence on the ipsilateral side
is likely due to a spillover from the ﬂuorescence of
accumulated neutrophils in the temporal muscle.
Fluorescence intensities over the ipsilateral hemi-
sphere were signiﬁcantly higher in tMCAO mice that
received LIPO-6S-IDCC-labelled cells than in the cor-
responding sham-operated animals. Using ﬂuorescence
microscopy, we found accumulation of LIPO-6S-
IDCC-labelled neutrophil at the ischaemic territory,
conﬁrming that the detected NIRF contrast is due to
the accumulation of adoptively transferred neutrophils.
Longitudinal NIRF imaging in ischaemic mice
revealed an early presence of neutrophils starting imme-
diately after onset of reperfusion, which shows that
neutrophils are among the ﬁrst immune cells that
respond to an ischaemic insult. Neutrophil accumula-
tion peaked at 18 h after reperfusion. Previous studies
assessing neutrophil accumulation in the brain of
C57BL/6 mice after 1 h of tMCAO using ﬂow cytome-
try and immunohistochemistry showed considerably
variability in dynamics, i.e. to peak at 18–24 h,32 at
48 h42 and at 3 days after reperfusion.40 Fluorescence
signals from neutrophils in the ischaemic hemisphere
remained elevated up to 48 h after reperfusion, indicat-
ing that neutrophils might have a prolonged lifespan,
compared with 11 h under homeostatic conditions,43
which is mediated by pro-survival cytokines and che-
mokines in the ischaemic lesion.44 Taken together, the
ﬁndings show that NIRF imaging is capable to non-
invasively monitor the dynamics of the neutrophil
response after cerebral ischaemia in vivo. A general dis-
advantage of the presented approach is that the adop-
tive transfer of labelled neutrophils alters the neutrophil
count in the recipient mouse signiﬁcantly.45
The dynamics of the neutrophil response in the per-
ipheral circulation was diﬀerent from that in the ischae-
mic territory. Signiﬁcantly increased levels of
circulating neutrophil were detected at 0.5 h after reper-
fusion, which was likely due to a rapid egress of neu-
trophils from the bone marrow reserve into the
circulation.41 However, a similar extent of neutrophil
mobilization was also observed in sham-operated ani-
mals indicating that the eﬀect on circulating neutrophils
is mainly due to surgery and not to ischaemia. In
contrast, the growing ischaemic lesion did not seem to
(further) mobilize neutrophils within the circulation,
which returned to baseline within 24 h after reperfusion,
at which high levels of neutrophils were detected in the
ischaemic brain region.
To our surprise, we detected ﬂuorescence signals in
tMCAO and sham-operated mice after adoptive trans-
fer of LIPO-6S-IDCC-labelled neutrophils on the
extracranial ipsilateral regions. Immunohistochemistry
demonstrated accumulation of neutrophils in the tem-
poral muscles. The tMCAO model requires ligation of
the ECA and thereby restricts perfusion to the extra-
cerebral ECA territory. For rats, the tMCAO proced-
ure has been reported to cause tissue damage in muscles
of the ECA territory (including muscles for mastication
and swallowing) with negative consequences on out-
come.46 It is conceivable that ECA ligation has also
functional implications in the widely used tMCAO
mouse model. However, to our knowledge, this has
not yet been investigated. Beside functional implica-
tions, neutrophil accumulation in the ipsilateral
muscle might have also aﬀected quantiﬁcation of ﬂuor-
escence signals. ROIs were drawn carefully to measure
only over the brain regions excluding extracerebral
tissue (Figure 4(a)). In sham-operated animals, the nor-
malized ﬂuorescence intensities was found to be about
10% higher over the ipsilateral hemisphere compared
with the contralateral side, despite no detectable neu-
trophil accumulation in the brain. This indicates that
there is spillover from ﬂuorescence of labelled neutro-
phils from the ipsilateral muscle into the brain region.
During inﬂammation, circulating neutrophils are
recruited from the vessels via rolling, arrest and diape-
desis, guided by endothelial adhesion molecules and
chemokines.4 However, if mediators of the multistep
adhesion cascade regulate neutrophil recruitment at
the cerebral vasculature following transient ischaemia
is hitherto unknown. We have used NIRF imaging to
study the role of a4-integrins that has been implicated
in neutrophil arrest to the endothelium,4 but is also
expressed on other leukocyte subpopulations.15 We
observed a signiﬁcant reduction in normalized ﬂuores-
cence intensities in mice that received an antibody
against a4-integrin at 18 and 24 h after reperfusion
compared with control, while at 48 h, no diﬀerences
between the groups was detected.
Immunohistochemistry, though performed in only a
few animals, conﬁrmed our NIRF data at 48 h after
reperfusion. However, we did not investigate earlier
time points. This ﬁndings support a role of VLA-4
with any of its endothelial ligands, VCAM-1, ﬁbronec-
tin or JAM-B in mediating neutrophil traﬃcking to the
brain after cerebral ischaemia.
The neutrophil response clearly occurs during the
acute stage when substantial secondary lesion growth
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occurs.30 With immunohistochemistry, we found only
low numbers of neutrophils around the ischaemic
lesion. Recent studies indicate that these neutrophils
do not inﬁltrate the brain parenchyma, but rather
remain restricted to luminal surfaces or perivascular
spaces of cerebral vessels including the leptomenin-
ges.32,34 Neutrophils might still exert their deleterious
action via interaction with the vasculature. It has been
shown that neutrophils can release cytokines, proteases
and reactive oxygen species during an oxidative burst
and are involved in microvascular disturbances,47 and
blood–brain barrier damage.12 In addition, neutrophils
might contribute to secondary thrombus formation
after cerebral ischaemia as they interact with platelets,
participate in ﬁbrin cross-linkage and trigger thrombin
activation by inducing the extrinsic tissue factor/FVIIa
pathway.14 In our study, blocking of a4-integrin led to
a reduction of the ischaemic lesion at 48 h after reperfu-
sion. Anti-a4-integrin antibody-mediated treatment,
has so far yielded contradictory results for its neuro-
protective eﬀects following cerebral ischaemia in
rodents. While several previous studies have demon-
strated a reduction of the ischaemic damage and
improved functional deﬁcits after that anti-a4-integrin
antibody treatment,19,15,48,49 two studies reported no
eﬀect of treatment on the ischaemic lesion.50,51 The dif-
ference in the neuroprotective eﬃcacy might be attrib-
uted to diﬀerent batches of antibodies used, or
diﬀerences in housing and experimental conditions
that might aﬀect the inﬂammatory response following
cerebral ischaemia.52,53 However, we also calculated the
group size according to normalized ﬂuorescence inten-
sities as a primary end point. For the cerebral lesion,
the present study was underpowered (power¼ 0.67).
Preclinical multi-centre studies are more suited to
address this question and to conduct treatment studies
with suﬃcient statistical power. Indeed, such a trial
with large pooled data samples demonstrated that
anti-a4-integrin antibody did not reduce lesion size
after ﬁlament tMCAO in the mouse.51
In future studies, we want to reﬁne our current
approach and use molecular probes that can directly
visualize neutrophils function to elucidate how neutro-
phils partake in ischemic tissue injury. NIRF
imaging might constitutes an attractive tool to study
the neutrophil response in experimental models of cere-
bral ischaemia and potentially in other inﬂammatory
diseases.
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